Loading data
CMPSNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 118.44 m USD | 119.04 m USD | 87.52 m USD | 65.05 m USD | 44.03 m USD |
| Operating profit | -179.04 m USD | -178.21 m USD | -136.92 m USD | -110.4 m USD | -83.22 m USD |
| Interest expense | — | — | 2.2 m USD | 0 USD | 0 USD |
| Profit before tax | -290.34 m USD | -153.53 m USD | -117.68 m USD | -91.1 m USD | -71.54 m USD |
| Income tax expense | -2.47 m USD | 1.59 m USD | 780 k USD | 408 k USD | 199 k USD |
| Net income (reported basis) | -269.77 m USD | -155.12 m USD | -118.46 m USD | -91.51 m USD | -71.74 m USD |
| Net income attributable to common shareholders | — | — | -118.46 m USD | -91.51 m USD | -71.74 m USD |
| Basic earnings per share | -3.08 USD/share | -2.3 USD/share | -2.32 USD/share | -2.16 USD/share | -1.79 USD/share |
| Diluted earnings per share | -3.08 USD/share | -2.3 USD/share | -2.32 USD/share | -2.16 USD/share | -1.79 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.